These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus. Van Vollenhoven RF; McGuire JL Ann Med Interne (Paris); 1996; 147(4):290-6. PubMed ID: 8952750 [TBL] [Abstract][Full Text] [Related]
3. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response. Barry NN; McGuire JL; van Vollenhoven RF J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429 [TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. van Vollenhoven RF; Park JL; Genovese MC; West JP; McGuire JL Lupus; 1999; 8(3):181-7. PubMed ID: 10342710 [TBL] [Abstract][Full Text] [Related]
7. An open study of dehydroepiandrosterone in systemic lupus erythematosus. van Vollenhoven RF; Engleman EG; McGuire JL Arthritis Rheum; 1994 Sep; 37(9):1305-10. PubMed ID: 7945493 [TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Chang DM; Lan JL; Lin HY; Luo SF Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233 [TBL] [Abstract][Full Text] [Related]
9. The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus. Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH Arthritis Rheum; 2004 Nov; 50(11):3591-5. PubMed ID: 15529389 [TBL] [Abstract][Full Text] [Related]
10. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Nordmark G; Bengtsson C; Larsson A; Karlsson FA; Sturfelt G; Rönnblom L Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258 [TBL] [Abstract][Full Text] [Related]
11. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH Ann Rheum Dis; 2010 Jun; 69(6):1144-7. PubMed ID: 19854713 [TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone in systemic lupus erythematosus. van Vollenhoven RF Rheum Dis Clin North Am; 2000 May; 26(2):349-62. PubMed ID: 10768216 [TBL] [Abstract][Full Text] [Related]
13. [Focus on dehydroepiandrosterone (DHEA)]. Meyer P; Meier CA Rev Med Suisse; 2005 Feb; 1(6):415-8. PubMed ID: 15786645 [TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone, a sex steroid metabolite in development for systemic lupus erythematosus. Merrill JT Expert Opin Investig Drugs; 2003 Jun; 12(6):1017-25. PubMed ID: 12783605 [TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone (DHEA). Med Lett Drugs Ther; 2005 May; 47(1208):37-8. PubMed ID: 15880085 [TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone in the treatment of systemic lupus erythematosus. van Vollenhoven RF Rheumatology (Oxford); 2000 Aug; 39(8):929-30. PubMed ID: 10952759 [No Abstract] [Full Text] [Related]
17. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. van Vollenhoven RF Expert Opin Pharmacother; 2002 Jan; 3(1):23-31. PubMed ID: 11772330 [TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus. Chang DM; Chu SJ; Chen HC; Kuo SY; Lai JH Ann Rheum Dis; 2004 Dec; 63(12):1623-6. PubMed ID: 15547086 [TBL] [Abstract][Full Text] [Related]
19. Prasterone and bone mineral density in women with systemic lupus erythematosus. Alexander T; Friel PN; Wright JV J Rheumatol; 2005 Dec; 32(12):2497; author reply 2497-8. PubMed ID: 16331796 [No Abstract] [Full Text] [Related]